The stimulation of glucose absorption and metabolism in rat jejunum by bradykinin: dependence on the composition of commercial diets

Apical GLUT2 and Cav1.3: regulation of rat intestinal glucose and calcium absorption

We have proposed a model of intestinal glucose absorption in which transport by SGLT1 induces rapid insertion and activation of GLUT2 in the apical membrane by a PKC betaII-dependent mechanism. Since PKC betaII requires Ca(2+) and glucose is depolarizing, we have investigated whether glucose absorption is regulated by the entry of dietary Ca(2+) through Ca(v)1.3 in the apical membrane. When rat jejunum was perfused with 75 mM glucose, Ca(2+)-deplete conditions, or perfusion with the L-type antagonists nifedipine and verapamil strongly diminished the phloretin-sensitive apical GLUT2, but not the phloretin-insensitive SGLT1 component of glucose absorption. Western blotting showed that in each case there was a significant decrease in apical GLUT2 level, but no change in SGLT1 level. Inhibition of apical GLUT2 absorption coincided with inhibition of unidirectional (45)Ca(2+) entry by nifedipine and verapamil. At 10 mM luminal Ca(2+), (45)Ca(2+) absorption in the presence of 75 mM glucose was 2- to 3-fold that in the presence of 75 mM mannitol. The glucose-induced component was SGLT1-dependent and nifedipine-sensitive. RT-PCR revealed the presence of Ca(v)beta(3) in jejunal mucosa; Western blotting and immunocytochemistry localized Ca(v)beta(3) to the apical membrane, together with Ca(v)1.3. We conclude that in times of dietary sufficiency Ca(v)1.3 may mediate a significant pathway of glucose-stimulated Ca(2+) entry into the body and that luminal supply of Ca(2+) is necessary for GLUT2-mediated glucose absorption. The integration of glucose and Ca(2+) absorption represents a complex nutrient-sensing system, which allows both absorptive pathways to be regulated rapidly and precisely to match dietary intake.

The active and passive components of glucose absorption in rat jejunum under low and high perfusion stress

In order to determine how perfusion design affects the relationship of the apparent "active" and "passive" components of glucose absorption, rat jejunum was perfused with 50 mM glucose under conditions of low and high mechanical stress. Phloretin or cytochalasin B was used to inhibit GLUT2 and phloridzin to inhibit SGLT1. In low stress perfusions, the ratios of the "passive" to the "active" components determined using phloretin and phloridzin were 2.2 and 0.43, respectively. This discrepancy was explained by the fact that phloridzin inhibits not only SGLT1 but also indirectly that part of the GLUT2-mediated component controlled by SGLT1 through the glucose-induced activation and recruitment of GLUT2 to the brush-border membrane. In high stress perfusions, the ratios of the "passive" to the "active" components determined using phloretin and phloridzin were 0.94 and 0.95, respectively; cytochalasin B gave 0.95. The identity of these results was explained by the observation that the passive component is not dependent on the active component, because glucose-induced activation and recruitment of GLUT2 does not occur in high stress perfusions. Simultaneous inhibition of SGLT1 and GLUT2 in high stress perfusions with phloridzin and cytochalasin B inhibited absorption by 92 +/- 7 %; non-carrier-mediated transport is therefore minimal. Our data provide support for the view that the term "facilitated" should be used to replace the term "passive" in describing the component now known to be mediated by GLUT2. The study of the mechanism and regulation of this facilitated component depends crucially on the design of the perfusion system.

Mechanism of beta-adrenergic agonist-induced transmural transport of glucose in rat small intestine. Regulation of phosphorylation of SGLT1 controls the function

The perfusion of rat small intestine with 10 microM epinephrine (Epi) or 10 microM norepinephrine resulted in significant increases in the amount of 3-O-[methyl-3H]-D-glucose transported from the mucosal to serosal side. The Epi-induced increases in glucose transport were coupled with selective increases in beta-adrenoceptor density in the mucosal membranes. Treatment with 0.1 microM okadaic acid increased glucose transport even in the absence of Epi, but that with 1 microM staurosporine or 60 microM N-[2-(methylamino)ethyl]-5-isoquinoline-sulfonamide dihydrochloride completely inhibited the increases in glucose transport induced by 10 microM Epi or 10 microM dibutyryl cAMP. The maximal binding sites (Bmax) of [3H]phlorizin in brush border membrane (BBM) from tissues perfused with Epi was increased, showing increases in the binding ability of the Na+/glucose cotransporter (SGLT1) to glucose. Phosphorylation and dephosphorylation of BBM with protein kinase A (PKA) and alkaline phosphatase resulted in increases and decreases in Bmax of [3H]phlorizin, respectively. The phosphorylation state of SGLT1 immunoprecipitated from BBM incubated with [gamma-32P]ATP-Mg2+ and PKA, and the analysis of phosphoamino acids composed of SGLT1 in rats given [32P]orthophosphate indicate the presence of potential sites for PKA-mediated phosphorylation of SGLT1 at serine. These findings indicate that the regulation of phosphorylation of SGLT1 leads to an alteration of its function and results in the control of glucose transport in the rat small intestine.

Rapid regulation of rat jejunal glucose transport by insulin in a luminally and vascularly perfused preparation

1. The regulation of glucose transport by physiological concentrations of insulin was investigated using a preparation of rat jejunum perfused in situ with 5 mM glucose on both sides. 2. Luminal uptake was 87% inhibited (P < 0.001) by 0.2 mM phlorizin, indicating that it occurred by means of the Na(+)-D-glucose cotransporter. Vascular uptake was completely abolished by 0.2 mM phloretin, indicating that it was facilitated in nature. 3. When infused into the vascular circuit, insulin (10(-11) to 10(-7) M) stimulated vascular, and inhibited luminal, glucose uptake to a similar extent. Maximal stimulation of vascular uptake was increased by 40% compared with control infusions (P < 0.01) and occurred at 10(-10) M insulin. These effects were independent of changes in metabolism and vascular glucose concentration. 4. The time taken for half-maximal stimulation of vascular uptake was 6.3 +/- 0.7 min and preceded that for inhibition of luminal uptake by 6.5 +/- 1.3 min (P < 0.02). 5. The rapid inhibition of luminal glucose uptake by the acute administration of insulin was also detected by perfusion of jejunal loops in vivo. 6. It is concluded that the transport steps involved in intestinal glucose uptake are subject to rapid regulation by physiological concentrations of insulin and that the initial site of action is on the vascular side.